Vanguard's VYM Offers Broader Diversification Than iShares, But HDV Shines With Its Higher Yield

Vanguard High Dividend Yield ETF (VYM) and iShares Core High Dividend ETF (HDV) trade off diversification and yield: VYM holds about 566 stocks with $81.3bn AUM, a 0.06% expense ratio, a 1‑yr total return of 5.74% and a 2.49% yield, while HDV is a 75‑stock, $11.7bn fund with a 0.08% fee, 1‑yr return of 2.06% and a higher 3.09% yield. VYM’s broader sector exposure (financials, tech, industrials), higher five‑year growth ($1,595 vs $1,433) and higher beta (0.85 vs 0.62) point to stronger recent total‑return diversification, whereas HDV’s consumer staples, energy and healthcare tilt and top‑heavy blue‑chip holdings offer greater current income but more concentration risk and slightly higher fees. Institutional investors should favor HDV if maximizing near‑term yield is the priority and they can accept idiosyncratic risk; choose VYM for lower cost, wider diversification and better recent total‑return performance.

Analysis

The Vanguard High Dividend Yield ETF (VYM) and iShares Core High Dividend ETF (HDV) present a clear trade-off between diversification and current income. VYM holds roughly 566 stocks with $81.3 billion AUM, a 0.06% expense ratio, a one‑year total return of 5.74% and a 2.49% dividend yield, while HDV holds 75 stocks with $11.7 billion AUM, a 0.08% expense ratio, a one‑year total return of 2.06% and a 3.09% dividend yield.

Over five years VYM turned $1,000 into $1,595 versus $1,433 for HDV and shows higher market sensitivity (beta 0.85 vs 0.62) with similar five‑year max drawdowns (-15.87% vs -16.52%). VYM is broadly weighted to financials (21%), technology (14%) and industrials (13%) with top holdings like Broadcom, JPMorgan and Exxon Mobil, while HDV is concentrated in consumer staples, energy and healthcare with top positions Exxon Mobil, Johnson & Johnson and AbbVie.

Implications are straightforward: VYM’s larger, lower‑fee portfolio favors investors seeking diversified dividend exposure and stronger recent total returns, whereas HDV’s higher 3.09% yield suits investors focused on current income and blue‑chip dividend payers but carries greater concentration and fee drag. The choice should hinge on whether an investor prioritizes near‑term yield or diversified total‑return potential.

Key Decisions for Investors

• Favor VYM for core dividend exposure if your priority is diversification and recent total‑return performance given its 566 holdings, $81.3bn AUM and five‑year growth to $1,595
• Choose HDV only when maximizing current income is the primary objective, recognizing its 3.09% yield versus VYM's 2.49% and the modest fee difference (0.08% vs 0.06%)
• If allocating to HDV, limit position size or use hedges to manage concentration risk from its consumer staples, energy and healthcare tilt and top holdings such as Exxon Mobil, Johnson & Johnson and AbbVie
• Monitor relative performance and dividend sustainability since HDV’s lower one‑ and five‑year total returns mean the income advantage could be eroded by fees or underperformance, prompting reallocation if that occurs